Preventing and treating acute gout attacks across the clinical spectrum: A roundtable discussion

Cleveland Clinic Journal of Medicine

Volumn 77, Issue SUPPL. 2, 2010, Pages

  Mandell, Brian F ^a   Edwards, N Lawrence ^b   Sundy, John S ^c   Simkin, Peter A ^d   Pile, James C ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGOUT AGENT; COLCHICINE; CORTICOSTEROID; INTERLEUKIN 1; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; URIC ACID;

ACUTE DISEASE; ARTICLE; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; GOUT; HUMAN; NEEDLE BIOPSY; SYNOVIAL FLUID;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY, NEEDLE; COLCHICINE; DIAGNOSIS, DIFFERENTIAL; GOUT; GOUT SUPPRESSANTS; HUMANS; INTERLEUKIN-1; NARCOTICS; SYNOVIAL FLUID; URIC ACID;

EID: 77954667126     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77.s2.01     Document Type: Article

References (36)

1. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classifilcation of the acute arthritis of primary gout. Arthritis Rheum 1977; 20:895-900.
2. Malik A, Schumacher HR, Dinnella JE, Clayburne GM. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. J Clin Rheumatol 2009; 15:22-24.
3. Janssens HJEM, Janssen M, van de Lisdonk EH, et al. Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care [letter]. Ann Rheum Dis 2010; Mar 16 [Epub ahead of print].
4. Lin Y-H, Hsu H-L, Huang Y-C, et al. Gouty arthritis in acute cerebrovascular disease. Cerebrovasc Dis 2009; 28:391-396.
5. Altman RD, Honig S, Levin JM, Lightfoot RW. Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. J Rheumatol 1988; 15:1422-1426.
6. Maccagno A, Di Giorgio E, Romanowicz A. Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout. Curr Med Res Opin 1991; 12:423-429.
7. Schumacher HR, Boice JA, Daikh DI, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002; 324:1488-1492.
8. Rubin BR, Burton R, Navarra S, et al. Effilcacy and safety profille of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis Rheum 2004; 50:598-606.
9. Shrestha M, Morgan DL, Moreden JM, et al. Randomized doubleblind comparison of the analgesic effilcacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Ann Emerg Med 1995; 26:682-686.
10. Ahern MJ, Reid C, Gordon TP, et al. Does colchicine work? The results of the filrst controlled study in acute gout. Aust N Z J Med 1987; 17:301-304.
11. Terkeltaub RA, Furst DE, Bennett K, et al. High vs low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the filrst multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010; 62:1060-1068.
12. Janssens HJ, Janssen M, van de Lisdonk EH, et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a doubleblind, randomised equivalence trial. Lancet 2008; 371:1854-1860.
13. Man CY, Cheung IT, Cameron PA, et al. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 2007; 49:670-677.
14. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21:1325-1327.
15. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9:R28.
16. Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum 2009; 38:411-419.
17. Colcrys [package insert]. Philadelphia, PA: Mutual Pharmaceutical Company; 2009.
18. Simkin PA, Gardner GC. Colchicine use in cyclosporine treated transplant recipients: how little is too much? J Rheumatol 2000; 27:1334-1337.
19. Dogukan A, Oymak FS, Taskapan H, et al. Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD): possible role of clarithromycin administration. Clin Nephrol 2001; 55:181-182.
20. Rollot F, Pajot O, Chauvelot-Moachon L, et al. Acute colchicine intoxication during clarithromycin administration. Ann Pharmacother 2004; 38:2074-2077.
21. Alayli G, Cengiz K, Canturk F, Durmus D, Akyol Y, Menekse EB. Acute myopathy in a patient with concomitant use of pravastatin and colchicine. Ann Pharmacother 2005; 39:1358-1361.
22. Atmaca H, Sayarlioglu H, Kulah E, Demircan N, Akpolat T. Rhabdomyolysis associated with gemfilbrozil-colchicine therapy. Ann Pharmacother 2002; 36:1719-1721.
23. Roger U, Lins H, Scherrmann JM, et al. Tetraparesis associated with colchicine is probably due to inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier. BMJ 2005; 331:613.
24. Levaquin [package insert]. Raritan, NJ: Ortho-McNeil; 2009.
25. Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 2003; 64:1328-1334.
26. Vistide [package insert]. Foster City, CA: Gilead Sciences; 2001.
27. -ibuprofen. Antimicrob Agents Chemother 2006; 50:1967-1972.
28. Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents. Drug interactions of clinical signifilcance. Drug Saf 1998; 18:83-97.
29. [2009] Red Book: Pharmacy's Fundamental Reference. 113th ed. Los Angeles, CA: RAmEx Ars Medica; 2009.
30. Odio CM, Ramirez T, Arias G, et al. Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 2003; 22:883-888.
31. Hung IF, Wu AK, Cheng VC, et al. Fatal interaction between clarithromycin and colchicine in patients with renal insuffilciency: a retrospective study. Clin Infect Dis 2005; 41:291-300.
32. Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther 2006; 8(suppl 1):S3-S9.
33. Kang EH, Lee EY, Lee YJ, et al. Clinical features and risk factors of postsurgical gout. Ann Rheum Dis 2008; 67:1271-1275.
34. Craig MH, Poole GV, Hauser CJ. Postsurgical gout. Am Surg 1995; 61:56-59.
35. Friedman JE, Dallal RM, Lord JL. Gouty attacks occur frequently in postoperative gastric bypass patients. Surg Obes Relat Dis 2008; 4:11-15.
36. Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353:2450-2461.